Design, RNA cleavage and antiviral activity of new artificial ribonucleases derived from mono-, di- and tripeptides connected by linkers of different hydrophobicity
- PMID: 26899594
- DOI: 10.1016/j.bmc.2016.02.007
Design, RNA cleavage and antiviral activity of new artificial ribonucleases derived from mono-, di- and tripeptides connected by linkers of different hydrophobicity
Abstract
A novel series of metal-free artificial ribonucleases (aRNases) was designed, synthesized and assessed in terms of ribonuclease activity and ability to inactivate influenza virus WSN/A33/H1N1 in vitro. The compounds were built of two short peptide fragments, which include Lys, Ser, Arg, Glu and imidazole residues in various combinations, connected by linkers of different hydrophobicity (1,12-diaminododecane or 4,9-dioxa-1,12-diaminododecane). These compounds efficiently cleaved different RNA substrates under physiological conditions at rates three to five times higher than that of artificial ribonucleases described earlier and displayed RNase A-like cleavage specificity. aRNases with the hydrophobic 1,12-diaminododecane linker displayed ribonuclease activity 3-40 times higher than aRNases with the 4,9-dioxa-1,12-diaminododecane linker. The assumed mechanism of RNA cleavage was typical for natural ribonucleases, that is, general acid-base catalysis via the formation of acid/base pairs by functional groups of amino acids present in the aRNases; the pH profile of cleavage confirmed this mechanism. The most active aRNases under study exhibited high antiviral activity and entirely inactivated influenza virus A/WSN/33/(H1N1) after a short incubation period of viral suspension under physiological conditions.
Keywords: Antiviral activity; Artificial ribonucleases; General acid/base catalysis; Influenza virus; RNA cleavage; Synthesis.
Copyright © 2016 Elsevier Ltd. All rights reserved.
Similar articles
-
Artificial ribonucleases inactivate a wide range of viruses using their ribonuclease, membranolytic, and chaotropic-like activities.Antiviral Res. 2016 Sep;133:73-84. doi: 10.1016/j.antiviral.2016.07.014. Epub 2016 Jul 28. Antiviral Res. 2016. PMID: 27476043
-
Inactivation of a non-enveloped RNA virus by artificial ribonucleases: honey bees and acute bee paralysis virus as a new experimental model for in vivo antiviral activity assessment.Antiviral Res. 2011 Sep;91(3):267-77. doi: 10.1016/j.antiviral.2011.06.011. Epub 2011 Jun 22. Antiviral Res. 2011. PMID: 21722669
-
Novel amphiphilic compounds effectively inactivate the vaccinia virus.FEBS Lett. 2012 Jun 4;586(11):1669-73. doi: 10.1016/j.febslet.2012.04.047. Epub 2012 May 3. FEBS Lett. 2012. PMID: 22673577
-
Artificial ribonucleases.Adv Inorg Biochem. 1994;9:41-74. Adv Inorg Biochem. 1994. PMID: 7511321 Review.
-
Design and synthesis of metal-free artificial ribonucleases.Protein Pept Lett. 2007;14(2):151-63. doi: 10.2174/092986607779816177. Protein Pept Lett. 2007. PMID: 17305602 Review.
Cited by
-
Host Defence RNases as Antiviral Agents against Enveloped Single Stranded RNA Viruses.Virulence. 2021 Dec;12(1):444-469. doi: 10.1080/21505594.2021.1871823. Virulence. 2021. PMID: 33660566 Free PMC article. Review.
-
Small molecule approaches to targeting RNA.Nat Rev Chem. 2024 Feb;8(2):120-135. doi: 10.1038/s41570-023-00569-9. Epub 2024 Jan 26. Nat Rev Chem. 2024. PMID: 38278932 Review.
-
Evolutionary Trends in RNA Base Selectivity Within the RNase A Superfamily.Front Pharmacol. 2019 Oct 9;10:1170. doi: 10.3389/fphar.2019.01170. eCollection 2019. Front Pharmacol. 2019. PMID: 31649540 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources